Literature DB >> 10997911

Divalent cation transport by the distal nephron: insights from Bartter's and Gitelman's syndromes.

D H Ellison1.   

Abstract

Elucidation of the gene defects responsible for many disorders of renal fluid and electrolyte homeostasis has provided new insights into normal and abnormal physiology. Identifying the causes of Gitelman's and Bartter's syndromes has greatly enhanced our understanding of ion transport by thick ascending limb and distal convoluted tubule cells. Despite this information, several phenotypic features of these diseases remain confusing, even in the face of molecular insight. Paramount among these are disorders of divalent cation homeostasis. Bartter's syndrome is caused by dysfunction of thick ascending limb cells. It is associated with calcium wasting, but magnesium wasting is usually mild. Loop diuretics, which inhibit ion transport by thick ascending limb cells, markedly increase urinary excretion of both calcium and magnesium. In contrast, Gitelman's syndrome is caused by dysfunction of the distal convoluted tubule. Hypocalciuria and hypomagnesemia are universal parts of this disorder. Yet although thiazide diuretics, which inhibit ion transport by distal convoluted tubule cells, reduce urinary calcium excretion, they have minimal effects on urinary magnesium excretion, when given acutely. This review proposes mechanisms that may account for the differences between the effects of diuretic drugs and the phenotypic features of Gitelman's and Bartter's syndromes. These mechanisms are based on recent insights from another inherited disease of ion transport, inherited magnesium wasting, and from a review of the chronic effects of diuretic drugs in animals and people.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997911     DOI: 10.1152/ajprenal.2000.279.4.F616

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  24 in total

Review 1.  The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease.

Authors:  Monique van Abel; Joost G J Hoenderop; René J M Bindels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

Review 2.  Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome.

Authors:  Jian Xie; Leonard Craig; Melanie H Cobb; Chou-Long Huang
Journal:  Pediatr Nephrol       Date:  2006-05-09       Impact factor: 3.714

Review 3.  Renal magnification by EGF.

Authors:  David H Ellison
Journal:  Nephrol Dial Transplant       Date:  2008-02-25       Impact factor: 5.992

4.  The voltage-gated K+ channel subunit Kv1.1 links kidney and brain.

Authors:  David H Ellison
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

Review 5.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

6.  Risk factors for pseudogout in the general population.

Authors:  Young Hee Rho; Yanyan Zhu; Yuqing Zhang; Anthony M Reginato; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2012-08-11       Impact factor: 7.580

7.  The Sweet Pee model for Sglt2 mutation.

Authors:  Joseph P Ly; Tuncer Onay; Karen Sison; Gavasker Sivaskandarajah; Venkata Sabbisetti; Lingli Li; Joseph V Bonventre; Ann Flenniken; Neal Paragas; Jon M Barasch; S Lee Adamson; Lucy Osborne; Janet Rossant; Jurgen Schnermann; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2011-01       Impact factor: 10.121

Review 8.  Basolateral Kir4.1 activity in the distal convoluted tubule regulates K secretion by determining NaCl cotransporter activity.

Authors:  Wen-Hui Wang
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

Review 9.  TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate.

Authors:  Tom Nijenhuis; Joost G J Hoenderop; René J M Bindels
Journal:  Pflugers Arch       Date:  2005-07-26       Impact factor: 3.657

10.  Gitelman syndrome: when will it turn into Gitelman disease?

Authors:  Peter Gross
Journal:  Pediatr Nephrol       Date:  2003-05-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.